CW Optics Announces Clinical Trial of Breakthrough Technology for the Detection of Intravenous Infiltration

Seaford, VA, August 27, 2010 --(PR.com)-- CW Optics, Inc. announced today the launch of a clinical trial at the Virginia Commonwealth University Health System to investigate the safety and efficacy of ivWatch®, a novel optical device for monitoring intravenous (IV) infusion sites for infiltration. Each year, there are approximately 150 million peripheral IV insertions in the United States and about 3% result in infiltration, or fluid leaks, which can cause pain, skin loss requiring plastic surgery, nerve damage, and amputation of the affected limb.

Currently, there are no devices on the market that continuously monitor infusion sites for infiltration.

The gold standard for infiltration detection is a subjective check by the nurse. The ivWatch® applies CW Optics' proprietary technology (patent to be issued November, 2010) to monitor signs of infiltration in realtime.

The trial is being conducted by Kevin Ward, M.D., Professor and Associate Chair in the VCU Department of Emergency Medicine, who said, "Health care is becoming steeped in a culture of patient safety. However, in order to advance patient safety to its fullest, technology should be created which matches the culture. The IV infiltration detection device is one such technology. Technology which identifies potentially harmful events at their earliest possible time will help ensure optimal patient care and comfort in a manner conducive to keeping health care professionals productive."

This trial is supported by the National Heart, Lung and Blood Institute under grant R44HL062008.

CW Optics expects ivWatch® to lead the way for realtime monitoring of infusion sites during IV therapy. More information on this trial is provided at http://clinicaltrials.gov/ct2/show/NCT01126710 and http://www.iv-watch.com/.

CW Optics is a privately-held technology company specializing in design and development of biophotonic devices for clinically important human physiological monitoring. CW Optics’ product pipeline is focused on noninvasive, optical diagnostic technologies based on complex photon scattering analysis - the technical expertise of the founders. Employment opportunities are available at CW Optics, see http://www.cwoptics.com/blog.

###